Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixivaptan in Euvolemic Hyponatremia (HARMONY)
NCT00876798Phase 3Completed
- Sponsor
- CardioKine
- Start
- Jun 2009
- Primary completion
- Nov 2010
- Countries
- 8
01
Overview
Phase 3, randomised, double-blind trial in Euvolemic hyponatremia comparing Lixivaptan Arm with Placebo Arm (2 arms). Primary endpoints: Serum Sodium Concentration at 6 months and Safety and Tolerability of Oral Lixivaptan at 6 months. Started Jun 2009; status: completed.
02
Drugs
lixivaptan
03
Conditions
Euvolemic hyponatremia
Beyond the preview
Go deeper on NCT00876798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00876798.